Trials / Completed
CompletedNCT06555705
Effect of Omega 3 Supplementation on the Heart Rate Variability in Obese Children
Effect of Omega 3 Supplementation on the Heart Rate Variability in Obese Children, a Clinical Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 5 Years – 12 Years
- Healthy volunteers
- Not accepted
Summary
Evidence shows that omega-3 fatty acids lower blood triglyceride levels, lower blood pressure, enhance insulin sensitivity, and improve heart rate variability (HRV) measures, all of which may be indicators of cardiovascular health.As a result, omega-3 fatty acid supplementation may be a low-cost strategy with little adverse effects for obese youngsters, perhaps delaying the development of chronic cardiovascular illnesses.
Detailed description
This is a two-armed study , the interventional group will be given omega 3 and the control group will be given a placebo and both will be examined for the heart rate variability
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Placebo | The control group will be given placebo for 3 months |
| DIETARY_SUPPLEMENT | Omega 3 | The interventional group will be given omega 3 for 3 months |
Timeline
- Start date
- 2024-04-03
- Primary completion
- 2024-08-25
- Completion
- 2024-09-03
- First posted
- 2024-08-15
- Last updated
- 2025-03-07
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06555705. Inclusion in this directory is not an endorsement.